109 related articles for article (PubMed ID: 1618375)
1. [Effect of antilymphocytic globulin on immunologic parameters in children with acquired aplastic anemia].
Nikitin DO; Gavrilova LV
Gematol Transfuziol; 1992 Jan; 37(1):15-7. PubMed ID: 1618375
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of acquired aplastic anemia in children with Soviet-produced antilymphocyte globulin].
Nikitin DO; Alekseev NA
Gematol Transfuziol; 1990 Jan; 35(1):23-5. PubMed ID: 2328899
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].
Yu F; Tang SQ; Wang JW
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):479-81. PubMed ID: 17178040
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to glycosylphosphatidyl-inositol anchored proteins (GPI-AP) in antithymocyte and antilymphocyte globulin: possible role for the expansion of GPI-AP deficient cells in aplastic anemia.
Breitinger HH; Rojewski MT; Schrezenmeier H
Ann Hematol; 2009 Sep; 88(9):889-95. PubMed ID: 19137453
[TBL] [Abstract][Full Text] [Related]
5. [Antilymphocyte globulin in the treatment of aplastic anemia].
Malesević M; Tukić L; Stamatović D; Trajković Z; Krstić C
Med Pregl; 1993; 46(7-8):291-5. PubMed ID: 7968829
[TBL] [Abstract][Full Text] [Related]
6. Severe aplastic anaemia: correlation of in vitro test with clinical response to immunosuppression in 20 patients.
Bacigalupo A; Podesta' M; Van Lint MT; Vimercati R; Cerri R; Rossi E; Risso M; Carella A; Santini G; Damasio E; Giordano D; Marmont AM
Br J Haematol; 1981 Mar; 47(3):423-32. PubMed ID: 6450608
[TBL] [Abstract][Full Text] [Related]
7. Correlation of response of aplastic anemia patients to antilymphocyte globulin with in vitro lymphocyte stimulatory effect: predictive value of in vitro test for clinical response.
Abe T; Matsuoka H; Kojima S; Kamachi Y; Tsuge I; Kodera Y; Matsuyama T
Blood; 1991 May; 77(10):2225-30. PubMed ID: 2029581
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of antilymphocyte and antithymocyte globulins for patients with severe aplastic anemia and pure red cell aplasia--analysis of immunologic parameters of peripheral lymphocytes concerning ALG and ATG therapy].
Kawauchi K; Sugiyama H; Watanabe H; Urabe A; Takaku F
Rinsho Ketsueki; 1990 Jan; 31(1):10-5. PubMed ID: 2107342
[TBL] [Abstract][Full Text] [Related]
9. [Incidence and characteristics of complications in aplastic anemia patients treated with antilymphocytic globulin].
Ganapiev AA; Abdulkadyrov KM; Afanas'ev BV
Ter Arkh; 2003; 75(8):68-71. PubMed ID: 14520856
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
11. Treatment of aplastic anemia with immunosuppressive agents.
Takaku F
Tokai J Exp Clin Med; 1986; 11 Suppl():197-204. PubMed ID: 3452242
[TBL] [Abstract][Full Text] [Related]
12. [Results of severe aplastic anemia treated with antilymphocytic globulin].
Morales-Polanco MR; Pizzuto-Chávez J; Izquierdo-Ramírez J; Farfán-Canto JM
Gac Med Mex; 1989; 125(3-4):97-101; discussion 102-4. PubMed ID: 2633949
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of immunosuppressive therapy for aplastic anemia].
Teramura M; Saito H; Kobayashi S; Hoshino S; Oshimi K; Mizoguchi H
Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
[TBL] [Abstract][Full Text] [Related]
14. [The comparative efficacy of splenectomy and antilymphocyte globulin therapy in patients with aplastic anemia].
Savchenko VG; Mikhaĭlova EA; Liubimova LS; Turbina NS; Ustinova EN; Mendeleeva LP; Zakharov GN; Askarov TU
Ter Arkh; 1990; 62(7):76-81. PubMed ID: 2251670
[TBL] [Abstract][Full Text] [Related]
15. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
[TBL] [Abstract][Full Text] [Related]
16. [The treatment results in patients with aplastic anemia using different doses of antilymphocyte globulin].
Abdulkadyrov KM; Ganapiev AA; Shilova ER; Popova TI; Rozanova OE; Katsadze IuL
Ter Arkh; 1995; 67(8):51-4. PubMed ID: 7482337
[TBL] [Abstract][Full Text] [Related]
17. Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSF.
Bacigalupo A; Piaggio G; Podestà M; Tong J; Pitto A; Figari O; Benvenuto F; Vassallo F; Tedone E; Grassia L; Van Lint MT; Gualandi F; Hoffman R
Haematologica; 1997; 82(2):133-7. PubMed ID: 9175313
[TBL] [Abstract][Full Text] [Related]
18. Suppression of PHA-induced human T-lymphocyte colony formation following in vivo administration of anti-lymphocyte globulin. Report of one case.
Ghio R; Pistoia V; Perata A; Marmont AM
Blut; 1983 Dec; 47(6):351-4. PubMed ID: 6606456
[TBL] [Abstract][Full Text] [Related]
19. Recovery from aplastic anemia after treatment with antilymphocyte globulin.
Silingardi V; Torelli U
Arch Intern Med; 1979 May; 139(5):582-3. PubMed ID: 443953
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of aplastic anemia with antilymphocyte globulin].
Mikhaĭlova EA; Savchenko VG; Maslova ER; Ustinova EN
Ter Arkh; 1997; 69(7):33-9. PubMed ID: 9424755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
